Previous 10 | Next 10 |
home / stock / aspcf / aspcf news
TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its third quarter 2021 financial and operating results on Tuesday, November 9, 2021 before the market opens. The company will also host a conference call on Tuesday, November 9...
TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today announced that it will participate in the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13-15 in...
TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today announced that it had accepted a Part 36 settlement offer made by Recipharm Limited (“Recipharm”), a wholly-owned ...
Acerus Pharmaceuticals Corporation (ASPCF) Q2 2021 Earnings Conference Call August 10, 2021 10:00 AM ET Company Participants Bob Motz - Chief Financial Officer Ed Gudaitis - President & Chief Executive Officer Conference Call Participants Presentation Operator Good morning, ladies and gen...
TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and six-month period ended June 30, 2021. Unless otherwise noted, all amounts are i...
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2021 financial and operating results on Tuesday, August 10, 2021 before the market opens. The company will also host a conference call on Tuesday, August 10,...
TORONTO, July 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB:ASPCF) today announced that, on June 15, 2021, it prevailed at a preliminary issue trial in which Recipharm Limited (“Recipharm”...
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a specialty pharmaceutical company focused on the commercialization of novel prescription products in Men’s Health, today announced that, effective July 1, 2021, an additional leadin...
TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“ Acerus ”) (TSX: ASP; OTCQB: ASPCF) today announced the voting results from its annual meeting of shareholders held on June 14, 2021 in Toronto, Ontario. The total number of shares represented ...
Acerus Pharmaceuticals Corporation (ASPCF) Q1 2021 Results Conference Call May 13, 2021 10:00 AM ET Company Participants Bob Motz - CFO Ed Gudaitis - President and CEO Conference Call Participants Presentation Operator Good morning, ladies and gentlemen, and welcome to the Q1 2021 Conference ...
News, Short Squeeze, Breakout and More Instantly...
Acerus Pharmaceuticals Corp Company Name:
ASPCF Stock Symbol:
OTCMKTS Market:
Acerus Pharmaceuticals Corp Website:
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- As announced on January 26, 2023, Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) and its subsidiaries were granted creditor protection pursuant to an order (the “ Initial Order ”) g...
TORONTO, March 14, 2023 (GLOBE NEWSWIRE) -- On January 26, 2023, Acerus Pharmaceuticals Corporation and certain of its subsidiaries (collectively, “ Acerus ”) were granted protection pursuant to an order (the “ Initial Order ”) issued under the Companies ...
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX: ASP; OTCQB: ASPCF) today announced that the Company and its subsidiaries, Acerus Biopharma Inc., Acerus Labs Inc. and Acerus Pharmaceuticals USA,...